[Cardiac amyloidosis: a case series of 14 patients, description and prognosis].

[1]  M. Dimopoulos,et al.  New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Moon,et al.  Updates in Cardiac Amyloidosis: A Review , 2012, Journal of the American Heart Association.

[3]  D. Dingli,et al.  Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  C. Journé,et al.  [Diagnosis of cardiac amyloidosis using magnetic resonance imaging: a new reliable, non-invasive technique to be validated]. , 2011, La Revue de medecine interne.

[5]  M. Gertz.  Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk‐stratification, and management , 2011, American journal of hematology.

[6]  N. Lamblin,et al.  Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging. , 2010, The American journal of medicine.

[7]  W. Manning,et al.  Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. , 2009, The American journal of cardiology.

[8]  James D. Thomas,et al.  Differentiation of hypertrophic cardiomyopathy and cardiac amyloidosis from other causes of ventricular wall thickening by two-dimensional strain imaging echocardiography. , 2009, The American journal of cardiology.

[9]  K. Klingel,et al.  Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. , 2008, Journal of the American College of Cardiology.

[10]  Keyur B Shah,et al.  Amyloidosis and the heart: a comprehensive review. , 2006, Archives of internal medicine.

[11]  R. Falk.  Diagnosis and Management of the Cardiac Amyloidoses , 2005, Circulation.

[12]  R. Falk,et al.  Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis , 2005, American journal of hematology.

[13]  P. Poole‐Wilson,et al.  Cardiovascular Magnetic Resonance in Cardiac Amyloidosis , 2005, Circulation.

[14]  J. Piette,et al.  AL cardiac amyloidosis and arterial thromboembolic events , 2005, Scandinavian journal of rheumatology.

[15]  T. Therneau,et al.  Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  T. Therneau,et al.  Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. , 2004, Blood.

[17]  R. Falk,et al.  High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study , 2004, Annals of Internal Medicine.

[18]  A. Balduini,et al.  Serum N-Terminal Pro–Brain Natriuretic Peptide Is a Sensitive Marker of Myocardial Dysfunction in AL Amyloidosis , 2003, Circulation.

[19]  J. Piette,et al.  Amyloidosis and cardiac involvement. , 2000, Annales de medecine interne.

[20]  R. Falk,et al.  The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. , 1998, QJM : monthly journal of the Association of Physicians.

[21]  W. O'Fallon,et al.  Primary systemic amyloidosis: multivariate analysis for prognostic factors in 168 cases. , 1986, Blood.

[22]  H. Adle-Biassette,et al.  [Amyloidosis: definition and classification]. , 1996, Archives d'anatomie et de cytologie pathologiques.

[23]  R. Kyle,et al.  Primary systemic amyloidosis: clinical and laboratory features in 474 cases. , 1995, Seminars in hematology.

[24]  R. Laraki.  L'amylose cardiaque. Revue générale , 1994 .